Skip to main content

Table 3 Amyloid progression model stages and ApoE-ε4 status

From: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study

 

N

Stage 0

Stage 1

Stage 2

Stage 3

Stage 4

ApoE-ε4 (+ve)

58

17 (10.5%)

12 (15.4%)

15 (37.5%)

13 (40.6%)

1 (25.0%)

ApoE-ε4 (−ve)

258

145 (89.9%)

66 (84.6%)

25 (62.5%)

19 (59.4%)

3 (75.0%)

All subjects

316

162

78

40

32

4

  1. The table presents the distribution of stageable participants (316 out of 318) in the INSIGHT-preAD cohort among the in vivo amyloid stages and their corresponding ApoE-ε4 status
  2. N number of participants in each category, ApoE-ε4 apolipoprotein E (ε4 allele)
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193